Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 28 06 2018
accepted: 06 08 2019
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 31 12 2019
Statut: epublish

Résumé

Immunization with attenuated whole Plasmodium sporozoites constitutes a promising vaccination strategy. Compared to replication-deficient parasites, immunization with replication-competent parasites confers better protection and also induces a type I IFN (IFN-1) response, but whether this IFN-1 response has beneficial or adverse effects on vaccine-induced adaptive immunity is not known. Here, we show that IFN-1 signaling-deficient mice immunized with replication-competent sporozoites exhibit superior protection against infection. This correlates with superior CD8 T cell memory including reduced expression of the exhaustion markers PD-1 and LAG-3 on these cells and increased numbers of memory CD8 T cells in the liver. Moreover, the adoptive transfer of memory CD8 T cells from the livers of previously immunized IFN-1 signaling-deficient mice confers greater protection against liver stage parasites. However, the detrimental role of IFN-1 signaling is not CD8 T cell intrinsic. Together, our data demonstrate that liver stage-engendered IFN-1 signaling impairs hepatic CD8 T cell memory via a CD8 T cell-extrinsic mechanism.

Identifiants

pubmed: 31477704
doi: 10.1038/s41467-019-11819-0
pii: 10.1038/s41467-019-11819-0
pmc: PMC6718385
doi:

Substances chimiques

Interferon Type I 0
Malaria Vaccines 0
Vaccines, Attenuated 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3950

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI114699
Pays : United States

Références

Cell. 2012 Mar 16;148(6):1284-92
pubmed: 22424235
Semin Immunopathol. 2012 Nov;34(6):787-92
pubmed: 23053392
Sci Transl Med. 2017 Jan 4;9(371):
pubmed: 28053159
J Immunol. 2002 Jul 1;169(1):375-83
pubmed: 12077267
J Exp Med. 1980 Jun 1;151(6):1504-13
pubmed: 6991628
PLoS Pathog. 2009 Apr;5(4):e1000399
pubmed: 19390607
Immunity. 2014 Dec 18;41(6):886-97
pubmed: 25526304
Int J Parasitol. 2004 Aug;34(9):991-6
pubmed: 15313126
J Clin Invest. 2014 Jun;124(6):2483-96
pubmed: 24789914
Nat Med. 2014 Jan;20(1):47-53
pubmed: 24362933
Infect Immun. 2015 Mar;83(3):1172-80
pubmed: 25583524
J Infect Dis. 2014 Nov 1;210(9):1508-16
pubmed: 24823625
J Immunol. 2013 May 15;190(10):5118-27
pubmed: 23585679
Science. 2013 Apr 12;340(6129):207-11
pubmed: 23580529
Cell Rep. 2014 Apr 24;7(2):436-447
pubmed: 24703850
J Immunol. 2015 Mar 1;194(5):2268-79
pubmed: 25646303
Nature. 2017 Feb 23;542(7642):445-449
pubmed: 28199305
Methods Mol Biol. 2013;923:549-66
pubmed: 22990804
Science. 2013 Apr 12;340(6129):202-7
pubmed: 23580528
J Immunol. 2018 Feb 15;200(4):1443-1456
pubmed: 29321276
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14017-22
pubmed: 18780790
Cell Rep. 2016 Oct 4;17(2):399-412
pubmed: 27705789
Infect Immun. 2018 Apr 23;86(5):
pubmed: 29440367
Nat Rev Immunol. 2012 Nov;12(11):749-61
pubmed: 23080391
J Immunol. 2015 Mar 15;194(6):2455-65
pubmed: 25747907
Infect Immun. 2014 Apr;82(4):1460-4
pubmed: 24421043
Clin Transl Immunology. 2016 Oct 21;5(10):e105
pubmed: 27867517
J Immunotoxicol. 2010 Mar;7(1):1-7
pubmed: 20017587
Sci Immunol. 2017 Mar;2(9):
pubmed: 28707003
J Immunol. 2010 Mar 1;184(5):2528-38
pubmed: 20097864
Genes Immun. 2013 Jul-Aug;14(5):302-9
pubmed: 23594961
Cell Microbiol. 2009 Mar;11(3):506-20
pubmed: 19068099
Annu Rev Immunol. 2014;32:157-87
pubmed: 24655294
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
FEBS J. 2017 Aug;284(16):2560-2568
pubmed: 28500775
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Nat Rev Immunol. 2010 Feb;10(2):80-1
pubmed: 20183893
Front Microbiol. 2014 Jun 06;5:272
pubmed: 24936199
Hum Vaccin. 2010 Jan;6(1):107-13
pubmed: 19838068
Front Immunol. 2018 Nov 09;9:2569
pubmed: 30473697
Expert Rev Vaccines. 2017 Jan;16(1):45-54
pubmed: 27327875
Immunity. 2016 Oct 18;45(4):889-902
pubmed: 27692609
Nat Rev Immunol. 2003 Apr;3(4):269-79
pubmed: 12669018
J Immunol. 1991 Feb 1;146(3):1020-5
pubmed: 1988490
Cell Host Microbe. 2011 Jun 16;9(6):451-62
pubmed: 21669394
Semin Immunol. 2012 Jun;24(3):209-17
pubmed: 22551764
Cell Host Microbe. 2019 Apr 10;25(4):565-577.e6
pubmed: 30905437
PLoS One. 2013 Apr 11;8(4):e60820
pubmed: 23593316
Infect Immun. 2014 Dec;82(12):5143-53
pubmed: 25267837

Auteurs

Nana K Minkah (NK)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA.

Brandon K Wilder (BK)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA.
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR, USA.

Amina A Sheikh (AA)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA.

Thomas Martinson (T)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA.
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR, USA.

Lisa Wegmair (L)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA.
Santis GmbH/Astrazeneca, Leverkusenstasse 54, 22761, Hamburg, Germany.

Ashley M Vaughan (AM)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA.

Stefan H I Kappe (SHI)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Ave N, Seattle, WA, USA. stefan.kappe@seattlechildrens.org.
Department of Global Health, University of Washington, Seattle, WA, USA. stefan.kappe@seattlechildrens.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH